 |
|
|
| |
A novel FXR agonist EDP-297 exerts anti-inflammatory and hepatoprotective effects in human liver 3D microtissues and in rodent models of liver injury and NASH
|
| |
| |
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Mary D.L. Chau, Manuel Roqueta-Rivera, Guoqiang Wang, Kelsey Garlick, Bindu Ramachandran, Kevin Mongeon, Nadya Bryan, Yat Sun Or, and Bryan Goodwin
Enanta Pharmaceuticals, Inc., Watertown, MA, USA
|
| |
|
|
|
|
|
